Randomized trial evaluates bleeding rates in patients using Impella devices with sodium bicarbonate and heparin, suggesting a potential standardization for anticoagulation management.
BBPS may be a safer option in those requiring longer duration of Impella support even in the absence of contraindications to heparin use and offers comparable efficacy to HBPS. The use of BBPS may be a solution towards standardizing and simplifying anticoagulation management in this population. Larger studies are needed to support the durability of Impella devices with BBPS.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: